| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
|
Kanda, Tatsuo
|
|
2018
|
13 |
2 |
p. 103-109
|
article
|
| 2 |
Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection
|
Mak, Lung-Yi
|
|
2019
|
13 |
2 |
p. 148-156
|
article
|
| 3 |
Goals and targets for personalized therapy for HCC
|
Couri, Thomas
|
|
2019
|
13 |
2 |
p. 125-137
|
article
|
| 4 |
Immunological cure of HBV infection
|
Lang, Julia
|
|
2019
|
13 |
2 |
p. 113-124
|
article
|
| 5 |
Influence of proton pump inhibitors on microbiota in chronic liver disease patients
|
Yamamoto, Kenta
|
|
2019
|
13 |
2 |
p. 234-244
|
article
|
| 6 |
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
|
Jain, Ashokkumar
|
|
2019
|
13 |
2 |
p. 190-198
|
article
|
| 7 |
Laser capture microdissection: techniques and applications in liver diseases
|
Aguilar-Bravo, Beatriz
|
|
2019
|
13 |
2 |
p. 138-147
|
article
|
| 8 |
Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
|
Hanafy, Amr Shaaban
|
|
2019
|
13 |
2 |
p. 165-172
|
article
|
| 9 |
Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd–Chiari syndrome on warfarin
|
Shukla, Akash
|
|
2019
|
13 |
2 |
p. 214-221
|
article
|
| 10 |
Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms
|
Jin, Ye
|
|
2019
|
13 |
2 |
p. 180-189
|
article
|
| 11 |
Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005–2016
|
Kim, Donghee
|
|
2019
|
13 |
2 |
p. 205-213
|
article
|
| 12 |
Serum ferritin as a biomarker for NAFLD: ready for prime time?
|
Shah, Raj A.
|
|
2019
|
13 |
2 |
p. 110-112
|
article
|
| 13 |
Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population
|
Jung, Ju Young
|
|
2018
|
13 |
2 |
p. 222-233
|
article
|
| 14 |
Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India
|
Sood, Ajit
|
|
2019
|
13 |
2 |
p. 173-179
|
article
|
| 15 |
The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
|
Obi, Shuntaro
|
|
|
13 |
2 |
p. 199-204
|
article
|
| 16 |
The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
|
Obi, Shuntaro
|
|
2019
|
13 |
2 |
p. 199-204
|
article
|
| 17 |
The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan
|
Su, Shih-Yung
|
|
2019
|
13 |
2 |
p. 157-164
|
article
|
Journal description